February presented another productive month for psychedelic research. This recap of the 21 most exciting articles covers intracellular neuroplasticity, brain measures, outcomes from psychedelic-assisted therapy

This January, outcomes of psychedelic use were closely examined. Studies looked at how experiences are integrated, how challenging experiences lead to growth, and the relationship

This December, one big trial on psilocybin for depression came out. Unlike other trials, the dose was relatively modest, given once, and the results were

Throughout November, we gained some fascinating new insights into the potential of psychedelic medicine as researchers from some of the world’s leading institutions published their

October was a relatively quiet month for psychedelic research. Nonetheless, we still gained some valuable new insights into the world of psychedelics. Natural language processing

September was an exciting month for many psychedelic researchers. Over the past month, we gained some positive insights into the effectiveness of ketamine infusions and esketamine using real-world data